Previous 10 | Next 10 |
NEW YORK, NY / ACCESSWIRE / December 7, 2022 / Aegis Capital Corp. acted as Sole Bookrunner on an $8 Million Underwritten Public Offering for RedHill Biopharma Ltd. (NASDAQ:RDHL). About RedHill Biopharma Ltd. RedHill Biopharma Ltd. is a specialty biopharmaceutical company primarily focused o...
RedHill Biopharma Closes $8.0 Million Underwritten Public Offering PR Newswire TEL AVIV, Israel and RALEIGH, N.C. , Dec. 6, 2022 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company,...
RedHill Biopharma Prices $8.0 Million Underwritten Public Offering PR Newswire TEL AVIV, Israel , and RALEIGH, N.C. , Dec. 2, 2022 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical compan...
RedHill Biopharma Announces Proposed Public Offering PR Newswire TEL AVIV, Israel and RALEIGH, N.C. , Dec. 1, 2022 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced t...
RedHill Biopharma Announces Q3/22 Results and Operational Highlights PR Newswire Non-binding agreement in principle reached with HCR on sale of Movantik to extinguish all debt obligations, to facilitate growth Q3/22 Net revenues of $17.6 million ; Operating...
RedHill Biopharma Announces Positive New Data with Opaganib for Nuclear Radiation Injury PR Newswire Positive in vivo results from a new study of opaganib in radiation-induced hematologic and renal toxicity reaffirms opaganib's potential protective impact on hematologi...
RedHill Biopharma ( NASDAQ: RDHL ) stock rose ~9% on Monday after the company said it reached a non-binding agreement with HCR Collateral Management to settle all debt obligations in exchange for rights to constipation drug Movantik (naloxegol). The potential ...
RedHill Accelerates Opaganib's Nuclear Radiation Protection Program - Positive Data Published Canada NewsWire Strong preclinical data, recently published in the International Journal of Molecular Sciences, from eight U.S government-funded in-vivo opaganib studies, supp...
RedHill Biopharma Reaches Agreement in Principle with HCR to Extinguish All Debt Obligations in Exchange for Movantik® PR Newswire TEL AVIV, Israel and RALEIGH, N.C. , Nov. 14, 2022 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("...
RedHill Biopharma Provides H1/22 Highlights and Q3/22 Estimates PR Newswire Financial update : Q2/22: Net revenues of $18.3 million ; Operating loss of $9.2 million ; Cash balance [1] of $43.2 million as of June 30, 2022 ; Restated Q1/22...
News, Short Squeeze, Breakout and More Instantly...
Redhill Biopharma Ltd. Company Name:
RDHL Stock Symbol:
NASDAQ Market:
Redhill Biopharma Ltd. Website:
RedHill Biopharma Strengthens Cash Balance, Settles Obligations and Removes Talicia® Lien PR Newswire TEL-AVIV, Israel and RALEIGH, NC , July 22, 2024 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biophar...
RedHill Biopharma Terminates License Agreement for Aemcolo® PR Newswire TEL-AVIV, Israel and RALEIGH, NC , July 9, 2024 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today ...
Windtree Therapeutics Inc. (WINT) is expected to report for Q1 2024 CohBar Inc. (CWBR) is expected to report for Q1 2024 hopTo Inc (HPTO) is expected to report for Q1 2024 Bitech Technologies Corporation (BTTC) is expected to report for Q1 2024 Roadzen Inc. (RDZN) is expected to r...